Document is current
Any future updates will be listed below
-
Authors
Gall, Gwenn Le
Cherifi, François
Divoux, Jordane
Florent, Romane
Christy, François
Leconte, Alexandra
San, Chankannira
Devillers, Amélie
Desmartin, Guillaume
Lecouflet, Lucie
Clarisse, Bénédicte
Ballesta, Samantha
Thorel, Lucie
Dubois, Brice
Harter, Valentin
Rousseau, Nathalie
Gaichies, Léopold
Martin-Françoise, Sandrine
Le Brun, Jean-François
Dolivet, Enora
Rouzier, Roman
Jeanne, Corinne
Blanc-Fournier, Cécile
Figeac, Martin
Leman, Raphaël
Castera, Laurent
Poulain, Laurent
Weiswald, Louis-Bastien
Joly, Florence
-
Funding
Funding for this research was provided by:
La Rochambelle (PENDOR)
Fédération nationale des Groupements des Entreprises Françaises dans la Lutte contre le Cancer (ENDOPARP)
- License Information
-
More Information
Article History
Received: 20 December 2024
Accepted: 23 January 2025
First Online: 11 February 2025
Declarations
:
: This study has received ethical approval from the « West II » ethical commitee (IDRCB: 2024-A01206-41) on July 16th, 2024. This committee is independent and not related with any affiliation of the authors. Any subsequent will of modification of the protocol would be submitted for approval from the committee. The clinical trial has been registered registered at ClinicalTrials.gov with the identifier NCT06603506 on September 19th, 2024. The study will be explained to the patients by the surgeons or the medical oncologists and an informed consent form will be obtained from all participants.
: Not applicable.
: The authors declare no competing interests.
